2-(1-methyl-1H-imidazol-4-yl)acetic acid

CAS No. 2625-49-2

2-(1-methyl-1H-imidazol-4-yl)acetic acid( —— )

Catalog No. M37575 CAS No. 2625-49-2

2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-(1-methyl-1H-imidazol-4-yl)acetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.
  • Description
    2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2625-49-2
  • Formula Weight
    140.14
  • Molecular Formula
    C6H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)CC=1N=CN(C1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DL-Homocysteinethiol...

    DL-Homocysteinethiolactone hydrochloride is a cysteine derivative that binds to and induces conformational changes in various plasma proteins slowing coagulation and inducing oxidative stress.?It decreases left ventricular systolic blood pressure and cardiac force and induces seizures in vivo.

  • 8-Hydroxy-2'-deoxygu...

    8-Oxo-dG is a good biomarker for risk assessment of various cancers and degenerative diseases.

  • Coenzyme Q9

    Coenzyme Q9 (CoQ9) is a normal constituent of human plasma.?CoQ9 in human plasma may originate as a product of incomplete CoQ10 biosynthesis or from the diet.